SHENYANG, China, May 4 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc.
(Nasdaq: SSRX), a leading China-based biotechnology company focused on
researching, developing, manufacturing and marketing biopharmaceutical
products, today announced that it will release financial results for the first
quarter ended March 31, 2009 after the US market closes on Tuesday, May 19,
2009.
Following the earnings announcement, 3SBio's senior management will host a
conference call at 5:00 am (Pacific) / 8:00 am (Eastern) / 8:00 pm
(Beijing/Hong Kong) on Wednesday, May 20, 2009 to discuss its 2009 first
quarter financial results and recent business activity.
The conference call may be accessed using the dial-in numbers below:
International Toll Dial-In Number: + 6567357955
China (Landline) 8008190121
(Mobile) 4006208038
U.K. 08082346646
U.S. 18665194004
Hong Kong 800933053
Conference ID: 97106460
A telephone replay will be available shortly after the call until May 27,
2009, at:
International Dial-In Number: + 61 2 8235 5000
U.S. Dial-in Number: + 18662145335
Conference ID: 97106460
A live webcast of the conference call and the replay will be available on
the investor relations page of 3SBio's website at
http://bbs.3sbio.com/en/News/xinvestors.aspx .
About 3SBio Inc.
3SBio Inc. is a leading, fully integrated biotechnology company focused on
researching, developing, manufacturing and marketing biopharmaceutical
products, primarily in China.
For more information, please visit 3SBio on the web at
http://www.3sbio.com .
For more information, please contact:
Investor Contact:
Bo Tan, CFO
3SBio Inc.
Tel: +86-24-2581-1820
Investor Relations (China):
Peter Schmidt
FD Beijing
Tel: +86-10-8591-1953
Investor Relations (US):
Evan Smith
John Capodanno
FD US
Tel: +1-212-850-5600
SOURCE 3SBio Inc.
